Skip to content

BBNX BBNX Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

AdaptHealth logo
AdaptHealthAHCO

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's operating lease right-of-use asset amortization?
BBNX (BBNX) reported operating lease right-of-use asset amortization of $402K in Q1 2026.
How has BBNX's operating lease right-of-use asset amortization changed year-over-year?
BBNX's operating lease right-of-use asset amortization increased by 33.6% year-over-year, from $301K to $402K.
What is the long-term trend for BBNX's operating lease right-of-use asset amortization?
Over 2 years (2023 to 2025), BBNX's operating lease right-of-use asset amortization has grown at a 22.7% compound annual growth rate (CAGR), from $865K to $1.3M.